Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis

INTRODUCTION: The use of renin-angiotensin system (RAS) inhibitors, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was alleged to cause a more severe course of novel coronavirus disease 2019 (COVID-19). METHODS: We systematically reviewed the pub...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cardiovasc Drugs
Autors principals: Hasan, Syed Shahzad, Kow, Chia Siang, Hadi, Muhammad Abdul, Zaidi, Syed Tabish Razi, Merchant, Hamid A.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Systematic Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486167/
https://ncbi.nlm.nih.gov/pubmed/32918209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00439-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars